[go: up one dir, main page]

ES502851A0 - Procedimiento para preparar n6-adenosina - Google Patents

Procedimiento para preparar n6-adenosina

Info

Publication number
ES502851A0
ES502851A0 ES502851A ES502851A ES502851A0 ES 502851 A0 ES502851 A0 ES 502851A0 ES 502851 A ES502851 A ES 502851A ES 502851 A ES502851 A ES 502851A ES 502851 A0 ES502851 A0 ES 502851A0
Authority
ES
Spain
Prior art keywords
adenosine
preparing
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES502851A
Other languages
English (en)
Other versions
ES8203916A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of ES8203916A1 publication Critical patent/ES8203916A1/es
Publication of ES502851A0 publication Critical patent/ES502851A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES502851A 1980-06-09 1981-06-08 Procedimiento para preparar n6-adenosina Granted ES502851A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15762580A 1980-06-09 1980-06-09
US06/229,824 US4340730A (en) 1980-06-09 1981-01-30 N6 -Substituted adenosines

Publications (2)

Publication Number Publication Date
ES8203916A1 ES8203916A1 (es) 1982-04-01
ES502851A0 true ES502851A0 (es) 1982-04-01

Family

ID=26854319

Family Applications (1)

Application Number Title Priority Date Filing Date
ES502851A Granted ES502851A0 (es) 1980-06-09 1981-06-08 Procedimiento para preparar n6-adenosina

Country Status (10)

Country Link
US (1) US4340730A (es)
AU (1) AU7139981A (es)
DE (1) DE3122784A1 (es)
DK (1) DK251281A (es)
ES (1) ES502851A0 (es)
FR (1) FR2483929A1 (es)
GB (1) GB2077725A (es)
IT (1) IT1171282B (es)
NL (1) NL8102745A (es)
SE (1) SE8103580L (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4388308A (en) * 1980-06-09 1983-06-14 G.D. Searle & Co. N6 -[(2-Hydroxypropyl)aryl]adenosines
FR2574798B1 (fr) * 1984-12-13 1987-11-20 Cepbepe Nouvelle adenosine substituee en n6 et medicament la contenant comme principe actif
US5284834A (en) * 1985-03-29 1994-02-08 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Adenosine functionalized congeners as cardiovascular treating agents for animals and methods for using same
US4968697A (en) * 1987-02-04 1990-11-06 Ciba-Geigy Corporation 2-substituted adenosine 5'-carboxamides as antihypertensive agents
US5030624A (en) * 1988-10-26 1991-07-09 G. D. Searle & Co. R-diastereomer of an N6 -[(2-hydroxypropyl)aryl]adenosine and its medicinal uses
US5032584A (en) * 1988-10-26 1991-07-16 G. D. Searle & Co. S-diastereomer of an n6 -((2-hydroxypropyl)aryl)adenosine and its medicinal uses
US5055569A (en) * 1989-10-19 1991-10-08 G. D. Searle & Co. N-(6)-substituted adenosine compounds
FR2665362B1 (fr) * 1990-08-03 1994-12-09 Cepbepe Substance contenant, comme principe actif, une adenosine substitutee en n6 et son application.
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
CN104497085B (zh) * 2015-01-16 2017-05-24 华东理工大学 腺苷衍生物及其用途
JP7420718B2 (ja) * 2017-12-05 2024-01-23 ビーエーエスエフ ソシエタス・ヨーロピア アミノ酸エステルの有機スルホン酸塩の製造方法及びアミノ酸エステルの有機スルホン酸塩

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE788958A (fr) * 1971-09-18 1973-03-19 Schering Ag Derives d'adenosine et leur procede de preparation
BE789773A (fr) * 1971-10-08 1973-04-06 Schering Ag Adenosines n6 -substituees et leur procede de
US4081534A (en) * 1973-09-11 1978-03-28 Burroughs Wellcome Co. Amino purine nucleosides as autoimmune suppressant agents

Also Published As

Publication number Publication date
IT8148632A0 (it) 1981-06-08
GB2077725A (en) 1981-12-23
ES8203916A1 (es) 1982-04-01
DK251281A (da) 1981-12-10
NL8102745A (nl) 1982-01-04
AU7139981A (en) 1981-12-17
IT1171282B (it) 1987-06-10
IT8148632A1 (it) 1982-12-08
US4340730A (en) 1982-07-20
DE3122784A1 (de) 1982-05-06
FR2483929A1 (fr) 1981-12-11
SE8103580L (sv) 1981-12-10

Similar Documents

Publication Publication Date Title
AR231137A1 (es) Procedimiento para preparar metoxifenetilimidazoles
ES505898A0 (es) Procedimiento para preparar derivados de pirimidona
ES502276A0 (es) Procedimiento para preparar derivados de piridoxina
MX158200A (es) Procedimiento para preparar dimetileter
AR229796A1 (es) Procedimiento para preparar quinoxalin-2-il-etenilcetona
ES523938A0 (es) Procedimiento para preparar n-fosfonometilglicina
AR227415A1 (es) Procedimiento catalitico para preparar alquilaminas
ES502851A0 (es) Procedimiento para preparar n6-adenosina
AR226634A1 (es) Procedimiento para preparar cligolaldehido
ES543691A0 (es) Procedimiento para preparar nuevos n-sustituido-2-(1-imida- zolil)-indoles
ES500738A0 (es) Procedimiento para preparar pirimidil-quinazolinas
MX6752E (es) Procedimiento para preparar derivados de carboestirilos
MX6699E (es) Procedimiento para preparar acil-ureas
MX6807E (es) Procedimiento para preparar oxaquinolicidinas
ES500796A0 (es) Procedimiento para preparar derivados de pirimidona
MX157614A (es) Procedimiento para preparar derivados de isohexido
AR226337A1 (es) Procedimiento para preparar kijanimicina
AR230629A1 (es) Procedimiento para preparar compuestos de dihalogenotriacinil-aminonaftol
ES525235A0 (es) Procedimiento para preparar n-fosfonometilglicina
ES525085A0 (es) Procedimiento para preparar n-alil-olalquil-tionocarbamatos
AR227304A1 (es) Procedimiento para preparar tiazoles
ES502356A0 (es) Procedimiento para preparar colorantes bisazoicos
ES498762A0 (es) Procedimiento para preparar benzonitrilos sustuituidos
ES506012A0 (es) Procedimiento para preparar compuestos de halogenotriazinilo
AR229509A1 (es) Procedimiento para preparar derivados de 2-halogeno-acetanilidas